A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
Clinical trial NCT00257075 · COMPLETED
Trial details
- NCT number
- NCT00257075
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.